Pendal Group’s Neurocrine Biosciences NBIX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,784	Closed	-$322K	–	547
2021 Q4	$322K	Buy	+3,784	New	+$322K	﹤0.01%	492
2021 Q3	–	Sell	-3,442	Closed	-$335K	–	629
2021 Q2	$335K	Buy	+3,442	New	+$335K	﹤0.01%	468